The company said the kit simplifies the RT-qPCR workflow by eliminating RNA extraction, reducing sample preparation time and limiting the number of handling steps required before gene expression analysis.
Under the revised agreement, Exor can raise its shareholding in Philips to up to 22% of the company’s issued ordinary share capital and voting rights, compared with the previous 20% limit.
Philips developed Alturion to simplify routine ultrasound examinations without compromising image quality.
The newly cleared technology aims to standardize routine ultrasound examinations, reduce variability between operators, and minimize the need for repeat scans.
The Rembra platform extends the use of computed tomography beyond traditional diagnostic radiology into radiation therapy planning.